Ownership history in BB BIOTECH AG · 14 quarters on record
This page tracks every 13F SEC filing in which BB BIOTECH AG reported a position in Sage Therapeutics, Inc. (SAGE). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2019 Q1 | UNCHANGED | 1,375,229 | — | 0% | 5.50% | $218.7M | — |
| 2018 Q4 | ADDED | 1,375,229 | +303,856 | +28.4% | 4.22% | $131.7M | — |
| 2018 Q3 | UNCHANGED | 1,071,373 | — | 0% | 4.00% | $151.3M | — |
| 2018 Q2 | ADDED | 1,071,373 | +68,934 | +6.9% | 4.84% | $167.7M | — |